| CAS No. | 2222755-14-6 | Cat. No. | BCP30970 |
| Name | |||
| Synonyms | RET-IN-1; ARRY-192; ARRY192; ARRY 192; | ||
| Formula | C29H31N9O3 | M. Wt | 553.63 |
| Description | LOXO-292 is an oral and selective investigational drug in clinical development for the treatment of patients with cancers that harbor abnormalities in the rearranged during transfection (RET) kinase. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | RET | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.